Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network. Under the agreement, Siemens will supply the organization’s entire portfolio of FDA-approved PET radiopharmaceutical agents at PETNET Solutions locations throughout the United States.
The US Oncology Network is one of the nation’s largest networks of community-based oncology physicians, conducting about 60,000 positron emission tomography (PET) scans annually. This agreement also extends to community practices engaged in McKesson Specialty Health’s Onmark Select Program. Under the agreement, Siemens’ PETNET Solutions also will provide The US Oncology Network-affiliated practices and Onmark Select Practices with its portfolio of products and services to expand patient access to premium PET imaging services.
